KYMR Competitors & Alternatives
Compare Kymera Therapeutics Inc with similar stocks in the same industry
Biotechnology
KYMR
Main Stock$110.40
Tradestie Score
61
Market Cap
$3.91B
Revenue Growth
0.6%
Analyst Upside
+12.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.51
|
$10.76B | - | 67 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$67.01
|
$10.74B | - | 57 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$59.20
|
$10.53B | 42.5 | 66 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$56.75
|
$10.49B | - | 44 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$83.08
|
$10.22B | - | 67 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$531.00
|
$10.01B | - | 66 | Compare |
|
TECH
Bio-Techne Corp.
|
$71.36
|
$9.33B | 101.9 | 53 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$85.90
|
$8.88B | 262.5 | 60 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$76.11
|
$8.77B | 26.7 | 58 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$183.95
|
$8.57B | - | 57 | Compare |
More KYMR Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry